男女羞羞视频在线观看,国产精品黄色免费,麻豆91在线视频,美女被羞羞免费软件下载,国产的一级片,亚洲熟色妇,天天操夜夜摸,一区二区三区在线电影
Chinadaily.com.cn
 
Go Adv Search

China's mums key to Nestle baby milk deal

Updated: 2012-04-25 11:19

(Agencies)

  Comments() Print Mail Large Medium  Small

LONDON/BEIJING - The rise of the middle-class Chinese working mothers helps explain why Nestle paid nearly $12 billion for Pfizer's baby food business and could leave rivals scrambling to catch up.

Across emerging markets, nowhere more than in China, women are increasingly keeping jobs after having children -- a big driving force behind 10 percent annual growth in the $30 billion a year baby food industry.

Foreign labels such as SMA, Promil and S-26 Gold, which Nestle will get with the Pfizer deal, have a definite edge. Nestle's products include Nan, Gerber, Lactogen and Nestogen, but are less well known in China.

Baby milk was the foundation of the world's biggest food company, established in 1866 when German pharmacist Henri Nestle introduced a substitute for mothers who could not breast-feed.

Paying more for the Pfizer unit than the $10 billion that analysts had expected, Nestle trumped a bid from Danone and Mead Johnson.

The Pfizer nutrition business has 85 percent of its sales in emerging markets, and a quarter of sales in China.

Fuelled by 16 million new births a year, annual growth rates for China's baby formula market have been as high as 20 percent over the last five years. The market is forecast to double to $16 billion by 2016.

"The key strategic attraction of the deal in our view is Pfizer's No 5 position in the Chinese infant formula market where despite being global No 1 player in infant formula, Nestle has a relatively weak presence," said analyst Robert Dickinson at brokers Citi.

The Swiss giant is already market leader in milk formula in Latin America, Africa and the Middle East. This brings it the No 1 spot in Asia with its presence outside China counted too.

Globally, Nestle's baby food market share will rise to 25 percent from 19 percent - although this is likely to fall slightly after sell-offs to ensure regulatory clearance. Mead has 16 percent, Danone 14 percent and Abbott Laboratories 12 percent.

Few options for competitors

The Nestle-Pfizer business in China would only have a combined 12 percent market share behind Mead's leading 16 percent and Danone on 14 percent, but that would still be a rise from 10th place and there may be room for expansion.

Analysts looking at China expect the number of middle class households to double to 100 million by 2015.

主站蜘蛛池模板: 德庆县| 湛江市| 布拖县| 黄龙县| 赤峰市| 旺苍县| 柳州市| 汉中市| 澄迈县| 云阳县| 聊城市| 万荣县| 长岛县| 延川县| 新余市| 威远县| 鞍山市| 安义县| 大英县| 馆陶县| 页游| 潼南县| 保定市| 河北区| 手游| 灵寿县| 德化县| 巨鹿县| 巫溪县| 四子王旗| 雅安市| 武鸣县| 磴口县| 上饶县| 噶尔县| 彰武县| 恩施市| 贺兰县| 呈贡县| 平泉县| 金塔县| 米林县| 伊吾县| 钟山县| 云霄县| 吴桥县| 仁化县| 青阳县| 浦县| 青龙| 武宁县| 龙南县| 开阳县| 清新县| 瑞丽市| 皋兰县| 紫阳县| 西和县| 南木林县| 揭西县| 当阳市| 唐山市| 长治县| 蓝山县| 天水市| 信宜市| 甘孜| 涟水县| 剑川县| 阿拉善右旗| 齐齐哈尔市| 长顺县| 黔江区| 疏勒县| 泸水县| 河北省| 若羌县| 青川县| 杭锦后旗| 勐海县| 苍南县| 九龙城区|